Idexx Laboratories IDXX CAG — D&A

Other segment segments

Similar metrics at other companies

PAHCAnimal Health — D&A

$11.13M-2.1%

NEOGAnimal Safety — D&A

$2.4M-35.1%

CENTPet — D&A

$10.46M+10.1%

MTRXCorporate Segment — D&A

$66K+24.5%

BCPCAnimal Nutrition and Health — D&A

$1.86M+5.6%

CTB

CTBICorporate — D&A

$51K0.0%

Questions, answered.

What is Idexx Laboratories's CAG — D&A?

Idexx Laboratories (IDXX) reported CAG — D&A of $32.59M in Q4 2025.

How has Idexx Laboratories's CAG — D&A changed year-over-year?

Idexx Laboratories's CAG — D&A increased by 12.1% year-over-year, from $29.07M to $32.59M.

What is the long-term trend for Idexx Laboratories's CAG — D&A?

Over 4 years (2021 to 2025), Idexx Laboratories's CAG — D&A has grown at a 8.5% compound annual growth rate (CAGR), from $94.2M to $130.35M.

What does CAG — D&A mean?

This represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within the Companion Animal Group segment. It includes the depreciation of diagnostic equipment placed with customers under operating leases and the amortization of acquired technology or intellectual property. This non-cash expense is essential for understanding the true operational cost of maintaining the segment's asset base.